320 related articles for article (PubMed ID: 15832194)
1. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
[TBL] [Abstract][Full Text] [Related]
2. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T
J Hepatobiliary Pancreat Surg; 2007; 14(3):233-7. PubMed ID: 17520197
[TBL] [Abstract][Full Text] [Related]
4. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.
Mohri D; Asaoka Y; Ijichi H; Miyabayashi K; Kudo Y; Seto M; Ohta M; Tada M; Tanaka Y; Ikenoue T; Tateishi K; Isayama H; Kanai F; Fukushima N; Tada M; Kawabe T; Omata M; Koike K
J Gastroenterol; 2012 Feb; 47(2):203-13. PubMed ID: 22041919
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
[TBL] [Abstract][Full Text] [Related]
6. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?
Klöppel G; Kosmahl M
J Hepatol; 2006 Feb; 44(2):249-50. PubMed ID: 16360969
[No Abstract] [Full Text] [Related]
7. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
Lüttges J; Zamboni G; Longnecker D; Klöppel G
Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
[TBL] [Abstract][Full Text] [Related]
8. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
9. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
[TBL] [Abstract][Full Text] [Related]
10. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
[TBL] [Abstract][Full Text] [Related]
11. Senescence in intraductal papillary mucinous neoplasm of the pancreas.
Miyasaka Y; Nagai E; Ohuchida K; Fujita H; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
Hum Pathol; 2011 Dec; 42(12):2010-7. PubMed ID: 21733551
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
13. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
[TBL] [Abstract][Full Text] [Related]
14. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
[TBL] [Abstract][Full Text] [Related]
15. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
Miyasaka Y; Nagai E; Yamaguchi H; Fujii K; Inoue T; Ohuchida K; Yamada T; Mizumoto K; Tanaka M; Tsuneyoshi M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4371-7. PubMed ID: 17671118
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
Basturk O; Berger MF; Yamaguchi H; Adsay V; Askan G; Bhanot UK; Zehir A; Carneiro F; Hong SM; Zamboni G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Balci S; Allen P; Ikari N; Takeuchi S; Akagawa H; Kanno A; Shimosegawa T; Morikawa T; Motoi F; Unno M; Higuchi R; Yamamoto M; Shimizu K; Furukawa T; Klimstra DS
Mod Pathol; 2017 Dec; 30(12):1760-1772. PubMed ID: 28776573
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas.
Sakamoto H; Kuboki Y; Hatori T; Yamamoto M; Sugiyama M; Shibata N; Shimizu K; Shiratori K; Furukawa T
Mod Pathol; 2015 Feb; 28(2):261-7. PubMed ID: 25081753
[TBL] [Abstract][Full Text] [Related]
19. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?
Wada K; Takada T; Yasuda H; Amano H; Yoshida M; Sugimoto M; Irie H
J Gastrointest Surg; 2004; 8(3):289-96. PubMed ID: 15019925
[TBL] [Abstract][Full Text] [Related]
20. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.
Brody JR; Witkiewicz A; Williams TK; Kadkol SS; Cozzitorto J; Durkan B; Pasternack GR; Yeo CJ
Mod Pathol; 2007 Dec; 20(12):1238-44. PubMed ID: 17906614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
